CASTRATION-RESISTANT PROSTATE CANCER
Clinical trials for CASTRATION-RESISTANT PROSTATE CANCER explained in plain language.
Never miss a new study
Get alerted when new CASTRATION-RESISTANT PROSTATE CANCER trials appear
Sign up with your email to follow new studies for CASTRATION-RESISTANT PROSTATE CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Combination drug trial for tough prostate cancer halted early
Disease control TerminatedThis study tested a combination of two drugs, denosumab and enzalutamide, in men with advanced prostate cancer that no longer responds to hormone therapy and has spread to the bones. The goal was to see if the combination could delay cancer growth better than historical results w…
Matched conditions: CASTRATION-RESISTANT PROSTATE CANCER
Phase: PHASE2 • Sponsor: Cancer Trials Ireland • Aim: Disease control
Last updated May 26, 2026 03:24 UTC
-
Cancer combo trial halted early: no breakthrough yet
Disease control TerminatedThis study tested a new drug (SOT101) combined with pembrolizumab in 166 people with advanced solid tumors like lung, colon, and ovarian cancer. The goal was to see if the combo could shrink tumors. The trial was stopped early, and it is not a cure—patients still need ongoing tre…
Matched conditions: CASTRATION-RESISTANT PROSTATE CANCER
Phase: PHASE2 • Sponsor: SOTIO Biotech AG • Aim: Disease control
Last updated May 26, 2026 03:12 UTC
-
Promising prostate cancer combo study halted before results
Disease control TerminatedThis study tested a combination of two drugs, cabozantinib and abiraterone, in men with a type of advanced prostate cancer that had spread to the bones and no longer responded to standard hormone therapy. The goal was to see if the combination could delay cancer growth or death. …
Matched conditions: CASTRATION-RESISTANT PROSTATE CANCER
Phase: PHASE2 • Sponsor: Exelixis • Aim: Disease control
Last updated May 19, 2026 11:47 UTC